KLAR Q1 2026 Earnings Net Loss Narrows Sharply Beating Estimates by Wide Margin VICI Q1 2026 Earnings Strong EPS Surprise of 1443 Despite Flat Stock Reaction PDF Solutions Q1 2026 Earnings Strong EPS Beat Drives Positive Market Reaction Atea Pharmaceuticals Q1 2026 Earnings Narrower Loss Beats Expectations Stock Edges Higher KZIA Q1 2026 Earnings EPS Misses Expectations Amid Clinical Progress Stock Rises Iovance Biotherapeutics Q1 2026 Earnings EPS Misses Estimates but Stock Rises on Operational Momentum